Director, Chief Executive Officer · SUTRO BIOPHARMA, INC. · Common Stock
Side
F
Value
$6,009
Shares
282
Price
$21.31
Executed
Mar 4, 2026
Disclosed
Mar 6, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Mar 4 executedMar 6, 2026 disclosed
STRO · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Tax withholding — administrative, little informational value
Relative size+1 / 25
$6K reported value · 1.3% of prior position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Chung Jane filed this Form 4 reporting a tax withholding of STRO on Mar 4, 2026. It became public on Mar 6, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, Chief Executive Officer
Chung Janecik:0001872398
Issuer
SUTRO BIOPHARMA, INC.cik:0001382101
Revision history · 0
No field has changed since this record was first ingested.
